Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2026-01-28 @ 2:44 AM
Study NCT ID:
NCT01390792
Status:
COMPLETED
Last Update Posted:
2017-05-16
First Post:
2011-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Influenza, Human | View |
Keywords: